臨床泌尿器科65巻11号

2011年10月発行

セミナー 基礎研究は面白い―私の体験・3

私と基礎研究

著者： 榎田英樹¹

所属機関： ¹鹿児島大学医学部泌尿器科学教室

ページ範囲：P.843 - P.850

文献概要

要約　日本では大学に在籍する医師（M.D.）が，希望すれば大学院進学などの手段で基礎研究をする機会が与えられ，そのほとんどが博士（Ph.D.）を取得できる。しかし，米国と比べてその価値は実際いかがなものか疑問もある。臨床につながるような基礎研究を考案して実行することがM.D. の使命と言えよう。本稿では，筆者が米国留学を通して感じた点や，現在行っている基礎研究の面白さを解説して今後の基礎研究のあるべき姿を探る。

参考文献

1）Enokida H, Gotanda T, Oku S, et al：Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line. Jpn J Cancer Res 93：1037-1046, 2002

2）Ichimi T, Enokida H, Okuno Y, et al：Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125：345-352, 2009

3）Kano M, Seki N, Kikkawa N, et al：miR-145, miR-133a and miR-133b：tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127：2804-2814, 2010

4）Zaman MS, Chen Y, Deng G, et al：The functional significance of microRNA-145 in prostate cancer. Br J Cancer 103：256-264, 2010

5）Wang CJ, Zhou ZG, Wang L, et al：Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 26：27-34, 2009

6）Radojicic J, Zaravinos A, Vrekoussis T, et al：MicroRNA expression analysis in triple-negative（ER, PR and Her2/neu）breast cancer. Cell Cycle 10：507-517, 2011

7）Gao P, Wong CC, Tung EK, et al：Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol 54：1177-1184, 2011

8）Volinia S, Galasso M, Costinean S, et al：Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20：589-599, 2010

9）Chiyomaru T, Enokida H, Tatarano S, et al：miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102：883-891, 2010

10）Pelosi G, Pastorino U, Pasini F, et al：Independent prognostic value of fascin immunoreactivity in stage Ⅰ non-small cell lung cancer. Br J Cancer 88：537-547, 2003

11）Zhang H, Xu L, Xiao D, et al：Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 59：958-964, 2006

. Am J Pathol 162：69-80, 2003

13）Grothey A, Hashizume R, Ji H, et al：C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 19：4864-4875, 2000

14）Maitra A, Adsay NV, Argani P, et al：Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16：902-912, 2003

15）Darnel AD, Behmoaram E, Vollmer RT, et al：Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res 15：1376-1383, 2009

16）Lin CK, Chao TK, Yu CP, et al：The expression of six biomarkers in the four most common ovarian cancers：correlation with clinicopathological parameters. APMIS 117：162-175, 2009

17）Goncharuk VN, Ross JS and Carlson JA：Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 29：430-438, 2002

18）Yamada Y, Enokida H, Kojima S, et al：MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma：correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102：522-529, 2011